|
1
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brabletz T, Hlubek F, Spaderna S,
Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and
metastasis in colorectal cancer: Epithelial-mesenchymal transition,
mesenchymal-epithelial transition, stem cells and β-catenin. Cells
Tissues Organs. 179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Costi R, Leonardi F, Zanoni D, Violi V and
Roncoroni L: Palliative care and end-stage colorectal cancer
management: The surgeon meets the oncologist. World J
Gastroenterol. 20:7602–7621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Serrano-Gomez SJ, Maziveyi M and Alahari
SK: Regulation of epithelial-mesenchymal transition through
epigenetic and post-translational modifications. Mol Cancer.
15:182016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xue C, Plieth D, Venkov C, Xu C and
Neilson EG: The gatekeeper effect of epithelial-mesenchymal
transition regulates the frequency of breast cancer metastasis.
Cancer Res. 63:3386–3394. 2003.PubMed/NCBI
|
|
10
|
Wang Y and Zhou BP: Epithelial-mesenchymal
transition in breast cancer progression and metastasis. Chin J
Cancer. 30:603–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayashida T, Jinno H, Kitagawa Y and
Kitajima M: Cooperation of cancer stem cell properties and
epithelial-mesenchymal transition in the establishment of breast
cancer metastasis. J Oncol. 2011:591427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y and Zhou BP: Epithelial-mesenchymal
transition - a hallmark of breast cancer metastasis. Cancer Hallm.
1:38–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sethi S, Macoska J, Chen W and Sarkar FH:
Molecular signature of epithelial-mesenchymal transition (EMT) in
human prostate cancer bone metastasis. Am J Transl Res. 3:90–99.
2010.PubMed/NCBI
|
|
14
|
Yan B, Jiang N and Niu YJ: Epithelial
mesenchymal transition in prostate cancer: Advances in current
research. Zhonghua Nan Ke Xue. 21:847–851. 2015.PubMed/NCBI
|
|
15
|
Khan MI, Hamid A, Adhami VM, Lall RK and
Mukhtar H: Role of epithelial mesenchymal transition in prostate
tumorigenesis. Curr Pharm Des. 21:1240–1248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Zijl F, Zulehner G, Petz M, Schneller
D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H and Mikulits
W: Epithelial-mesenchymal transition in hepatocellular carcinoma.
Future Oncol. 5:1169–1179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nurwidya F, Takahashi F, Murakami A and
Takahashi K: Epithelial mesenchymal transition in drug resistance
and metastasis of lung cancer. Cancer Res Treat. 44:151–156. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soltermann A, Tischler V, Arbogast S,
Braun J, Probst-Hensch N, Weder W, Moch H and Kristiansen G:
Prognostic significance of epithelial-mesenchymal and
mesenchymal-epithelial transition protein expression in non-small
cell lung cancer. Clin Cancer Res. 14:7430–7437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ikeguchi M, Makino M and Kaibara N:
Clinical significance of E-cadherin-catenin complex expression in
metastatic foci of colorectal carcinoma. J Surg Oncol. 77:201–207.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X and Chu KM: E-cadherin and gastric
cancer: Cause, consequence, and applications. BioMed Res Int.
2014:637308. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saito T, Oda Y, Kawaguchi K, Sugimachi K,
Yamamoto H, Tateishi N, Tanaka K, Matsuda S, Iwamoto Y, Ladanyi M,
et al: E-cadherin mutation and Snail overexpression as alternative
mechanisms of E-cadherin inactivation in synovial sarcoma.
Oncogene. 23:8629–8638. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shargh SA, Sakizli M, Khalaj V, Movafagh
A, Yazdi H, Hagigatjou E, Sayad A, Mansouri N, Mortazavi-Tabatabaei
SA and Khorshid HR Khorram: Downregulation of E-cadherin expression
in breast cancer by promoter hypermethylation and its relation with
progression and prognosis of tumor. Med Oncol. 31:2502014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan HB, Wang XF, Zhang Q, Tang ZQ, Jiang
YH, Fan HZ, Sun YH, Yang PY and Liu F: Reduced expression of the
chromatin remodeling gene ARID1A enhances gastric cancer cell
migration and invasion via downregulation of E-cadherin
transcription. Carcinogenesis. 35:867–876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanrahan K, O'Neill A, Prencipe M, Bugler
J, Murphy L, Fabre A, Puhr M, Culig Z, Murphy K and Watson RW: The
role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in
mediating docetaxel-resistant prostate cancer. Mol Oncol.
11:251–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rosivatz E, Becker I, Specht K, Fricke E,
Luber B, Busch R, Höfler H and Becker KF: Differential expression
of the epithelial-mesenchymal transition regulators snail, SIP1,
and twist in gastric cancer. Am J Pathol. 161:1881–1891. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jurgens G, Wieschaus E, Nussleinvolhard C
and Kluding H: Mutations affecting the pattern of the larval
cuticle in Drosophila melanogaster: II. Zygotic loci on the third
chromosome. Dev Genes Evol. 193:267–282. 1984.
|
|
30
|
Sandmann T, Girardot C, Brehme M,
Tongprasit W, Stolc V and Furlong EE: A core transcriptional
network for early mesoderm development in Drosophila melanogaster.
Genes Dev. 21:436–449. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reardon W and Winter RM: Saethre-Chotzen
syndrome. J Med Genet. 31:393–396. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zang C, Liu X, Li B, He Y, Jing S, He Y,
Wu W, Zhang B, Ma S, Dai W, et al: 6/STAT3/TWIST inhibition
reverses ionizing radiation-induced EMT and radioresistance in
esophageal squamous carcinoma. Oncotarget. 8:11228–11238.
2017.PubMed/NCBI
|
|
33
|
Fan Q, Qiu MT, Zhu Z, Zhou JH, Chen L,
Zhou Y, Gu W, Wang LH, Li ZN, Xu Y, et al: Twist induces
epithelial-mesenchymal transition in cervical carcinogenesis by
regulating the TGF-β/Smad3 signaling pathway. Oncol Rep.
34:1787–1794. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu HK, Kim JS, Lee HJ, Ahn JH, Lee SK,
Hong SW and Yoon Y: Suppression of colorectal cancer liver
metastasis and extension of survival by expression of
apolipoprotein(a) kringles. Cancer Res. 64:7092–7098. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lavilla-Alonso S, Abo-Ramadan U, Halavaara
J, Escutenaire S, Tatlisumak T, Saksela K, Kanerva A, Hemminki A
and Pesonen S: Optimized mouse model for the imaging of tumor
metastasis upon experimental therapy. PLoS One. 6:e268102011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thukkani N, Williams JL and Sonnenberg A:
Epidemiologic characteristics of patients with inflammatory bowel
disease undergoing colonoscopy. Inflamm Bowel Dis. 17:1333–1337.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li M, Luan F, Zhao Y, Hao H, Zhou Y, Han W
and Fu X: Epithelial-mesenchymal transition: An emerging target in
tissue fibrosis. Exp Biol Med. 241:1–13. 2016. View Article : Google Scholar
|
|
42
|
Tennakoon AH, Izawa T, Kuwamura M and
Yamate J: Pathogenesis of type 2 epithelial to mesenchymal
transition (EMT) in renal and hepatic fibrosis. J Clin Med. 5:pii:
E42015. View Article : Google Scholar
|
|
43
|
Avizienyte E, Brunton VG, Fincham VJ and
Frame MC: The SRC-induced mesenchymal state in late-stage colon
cancer cells. Cells Tissues Organs. 179:73–80. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bujko M, Kober P, Mikula M, Ligaj M,
Ostrowski J and Siedlecki JA: Expression changes of cell-cell
adhesion-related genes in colorectal tumors. Oncol Lett.
9:2463–2470. 2015.PubMed/NCBI
|
|
45
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ribatti D: Epithelial-mesenchymal
transition in morphogenesis, cancer progression and angiogenesis.
Exp Cell Res. 353:1–5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Steinestel K, Eder S, Schrader AJ and
Steinestel J: Clinical significance of epithelial-mesenchymal
transition. Clin Transl Med. 3:172014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rubio D, Garcia S, De la Cueva T, Paz MF,
Lloyd AC, Bernad A and Garcia-Castro J: Human mesenchymal stem cell
transformation is associated with a mesenchymal-epithelial
transition. Exp Cell Res. 314:691–698. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sipos F and Műzes G: Isolated lymphoid
follicles in colon: Switch points between inflammation and
colorectal cancer? World J Gastroenterol. 17:1666–1673. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Birchmeier W and Behrens J: Cadherin
expression in carcinomas: Role in the formation of cell junctions
and the prevention of invasiveness. Biochim Biophys Acta.
1198:11–26. 1994.PubMed/NCBI
|
|
52
|
Christofori G and Semb H: The role of the
cell-adhesion molecule E-cadherin as a tumour-suppressor gene.
Trends Biochem Sci. 24:73–76. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fukumura D and Jain RK: Tumor
microvasculature and microenvironment: Targets for
anti-angiogenesis and normalization. Microvasc Res. 74:72–84. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nakagawa H, Liyanarachchi S, Davuluri RV,
Auer H, Martin EW Jr, de la Chapelle A and Frankel WL: Role of
cancer-associated stromal fibroblasts in metastatic colon cancer to
the liver and their expression profiles. Oncogene. 23:7366–7377.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Satoh Y, Esche C, Gambotto A, Shurin GV,
Yurkovetsky ZR, Robbins PD, Watkins SC, Todo S, Herberman RB, Lotze
MT, et al: Local administration of IL-12-transfected dendritic
cells induces antitumor immune responses to colon adenocarcinoma in
the liver in mice. J Exp Ther Oncol. 2:337–349. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bouvet M, Tsuji K, Yang M, Jiang P, Moossa
AR and Hoffman RM: In vivo color-coded imaging of the interaction
of colon cancer cells and splenocytes in the formation of liver
metastases. Cancer Res. 66:11293–11297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Thalheimer A, Otto C, Bueter M, Illert B,
Gattenlohner S, Gasser M, Fein M, Germer CT and Waaga-Gasser AM:
Tumor cell dissemination in a human colon cancer animal model:
Orthotopic implantation or intraportal injection? Eur Surg Res.
42:195–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yamamoto N, Yang M, Jiang P, Xu M,
Tsuchiya H, Tomita K, Moossa AR and Hoffman RM: Determination of
clonality of metastasis by cell-specific color-coded
fluorescent-protein imaging. Cancer Res. 63:7785–7790.
2003.PubMed/NCBI
|
